Buying an Independent Pharmacy: Legal Issues That Can Affect the Transaction

By Ron Lanton III, Esq. | Lanton, Lanton & Sosa Law PLLC

Buying an independent pharmacy involves more than negotiating the purchase price and transferring ownership. A buyer must determine whether the pharmacy can continue operating, dispensing prescriptions, and receiving reimbursement after the transaction closes.

A pharmacy may have an established customer base, experienced employees, and a history of positive earnings. Those advantages can lose value if the buyer encounters licensing delays, unfavorable pharmacy benefit manager (PBM) contracts, or reimbursement problems that were not identified before signing the purchase agreement.

For prospective buyers, legal and operational due diligence should begin before the transaction terms are finalized.

What Is the Buyer Actually Acquiring?

The structure of the transaction matters. An asset purchase and an equity purchase can produce different results concerning liabilities, contracts, licenses, and regulatory obligations.

Buyers should review the pharmacy's financial records, existing debt, inventory, vendor agreements, lease obligations, employee arrangements, and pending legal or regulatory matters. Outstanding PBM audit findings, reimbursement disputes, or government investigations may affect the purchase price or require additional protections in the agreement.

Particular attention should be paid to the pharmacy's prescription volume and revenue sources. A business that depends heavily on a small number of payer contracts may face greater financial exposure if those relationships change after closing.

The purchase agreement should clearly address which assets and liabilities are being transferred, the representations made by the seller, and what happens if a material problem is discovered before closing.

Licensing and PBM Contracts Can Affect Closing

Pharmacy ownership changes may require notices, applications, new licenses, or approvals from state pharmacy boards and other regulatory authorities. Federal controlled-substance registration requirements must also be addressed when applicable.

The buyer should determine which approvals or registrations are necessary before operations can continue under the new ownership. The requirements vary by state and transaction structure.

PBM network participation deserves equal attention.

A buyer should not assume that the seller's existing PBM contracts will automatically remain in effect. Contract assignment restrictions, ownership-change notifications, credentialing requirements, and network participation rules may affect whether the pharmacy can continue submitting claims after closing.

Even a temporary interruption in reimbursement can create substantial cash-flow problems for a pharmacy that must continue purchasing inventory, paying employees, and serving patients.

The parties should address these requirements before agreeing on a closing date. Where appropriate, the purchase agreement should identify necessary approvals and establish what happens if they cannot be obtained.

Protecting the Business After Closing

The transition does not end when ownership changes.

Buyers may need to update payer enrollments, pharmacy records, supplier agreements, insurance arrangements, employment documentation, and other operational requirements. Existing leases may require landlord consent or renegotiation.

Specialty and long-term care pharmacies may have additional concerns involving accreditation, facility agreements, restricted pharmacy networks, and service obligations.

Management should develop a transition plan that identifies who is responsible for each filing, approval, contract, and operational change.

Buying an independent pharmacy can provide an established business and an opportunity for expansion. The transaction should be evaluated on more than its purchase price or reported earnings.

The buyer needs to know whether the pharmacy's licenses, contracts, reimbursement arrangements, and operating structure will support the business after closing.

Addressing those issues before signing can prevent costly surprises and help determine whether the proposed acquisition makes financial sense.

This article is for general informational purposes and does not constitute legal advice.

Previous
Previous

Physician Dispensing and Community Oncology: Legal Considerations for Practices Operating In-House Pharmacies

Next
Next

Planning for 2027: When Does Your Business Need Government Affairs Representation?